|

mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody Clinical Trials

1 actively recruiting trial

Also known as: mFOLFOX6

Pipeline

Phase 3: 1

Top Sponsors

  • Jun Huang1

Indications

  • pMMR/MSS Adenocarcinoma of the Colon or Rectum1
  • Colorectal Cancer (CRC)1
  • Cancer1

Other1 trial

mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.